Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/113189
Title: | Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet | Authors: | Razquin, Cristina Ruiz-Canela, Miguel Toledo, Estefania Hernández-Alonso, Pablo Clish, Clary B. Guasch-Ferré, Marta Li, Jun Wittenbecher, Clemens Dennis, Courtney Alonso-Gómez, Angel Fitó, Montse Liang, Liming Corella, Dolores Gómez-Gracia, Enrique Estruch, Ramon Fiol, Miquel Lapetra, Jose Serra Majem, Luis Ros, Emilio Aros, Fernando Salas-Salvadó, Jordi Hu, Frank B. Martínez-González, Miguel A. |
UNESCO Clasification: | 32 Ciencias médicas 3206 Ciencias de la nutrición |
Keywords: | Atrial Fibrillation Case–Control Heart Failure Kynurenine Mediterranean Diet, et al |
Issue Date: | 2021 | Journal: | The American journal of clinical nutrition | Abstract: | BACKGROUND: The tryptophan-kynurenine pathway is linked to inflammation. We hypothesize that metabolites implicated in this pathway may be associated with the risk of heart failure (HF) or atrial fibrillation (AF) in a population at high risk of cardiovascular disease. OBJECTIVES: We aimed to prospectively analyze the associations of kynurenine-related metabolites with the risk of HF and AF and to analyze a potential effect modification by the randomized interventions of the PREDIMED (Prevención con Dieta Mediterránea) trial with Mediterranean diet (MedDiet). METHODS: Two case-control studies nested within the PREDIMED trial were designed. We selected 324 incident HF cases and 502 incident AF cases individually matched with ≤3 controls. Conditional logistic regression models were fitted. Interactions with the intervention were tested for each of the baseline plasma metabolites measured by LC-tandem MS. RESULTS: Higher baseline kynurenine:tryptophan ratio (OR for 1 SD: 1.20; 95% CI: 1.01, 1.43) and higher levels of kynurenic acid (OR: 1.19; 95% CI: 1.01, 1.40) were associated with HF. Quinolinic acid was associated with AF (OR: 1.15; 95% CI: 1.01, 1.32) and HF (OR: 1.25; 95% CI: 1.04, 1.49). The MedDiet intervention modified the positive associations of kynurenine (Pinteraction = 0.006), kynurenic acid (Pinteraction = 0.008), and quinolinic acid (Pinteraction = 0.033) with HF and the association between kynurenic acid and AF (Pinteraction = 0.02). CONCLUSIONS: We found that tryptophan-kynurenine pathway metabolites were prospectively associated with higher HF risk and to a lesser extent with AF risk. Moreover, an effect modification by MedDiet was observed for the association between plasma baseline kynurenine-related metabolites and the risk of HF, showing that the positive association of increased levels of these metabolites and HF was restricted to the control group. | URI: | http://hdl.handle.net/10553/113189 | DOI: | 10.1093/ajcn/nqab238 | Source: | The American journal of clinical nutrition[EISSN 1938-3207],v. 114 (5), p. 1646-1654, (Noviembre 2021) |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
35
checked on Mar 30, 2025
WEB OF SCIENCETM
Citations
33
checked on Mar 30, 2025
Page view(s)
73
checked on May 23, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.